Trigyn Technologies Announces 40th AGM on Sep 30, 2026, for FY26 Results & Director Appointments
Trigyn Technologies Limited will hold its 40th AGM on September 30, 2026, to approve the FY26 audited financial statements. Key agenda items include re-appointing Dr. P. Raja Mohan Rao and appointing Mr. Narendra Bhandari as an Independent Director. E-voting facilities are available from September 27-29, 2026.
The AGM notification is important for shareholders as it outlines the financial performance review and board composition changes. The appointment of a new Independent Director can have a medium-term impact on corporate governance and strategic direction.
The announcement is a routine corporate event (AGM notification) with standard agenda items like financial statement adoption and director appointments. It does not contain any significantly positive or negative financial news or strategic developments.
Trigyn Technologies Limited has announced its 40th Annual General Meeting (AGM) will be held on Wednesday, September 30, 2026, at 3:30 PM IST via Video Conferencing (VC)/Other Audio Visual Means (OAVM). The meeting will transact ordinary and special business, including the adoption of the Audited Standalone and Consolidated Financial Statements for the Financial Year ended March 31, 2026.
The agenda also includes the re-appointment of Dr. P. Raja Mohan Rao as a Director retiring by rotation and the appointment of Mr. Narendra Bhandari as an Independent Director for a term of five consecutive years commencing from August 11, 2026, to August 10, 2031. This appointment is subject to Members' approval by way of a Special Resolution.
The company is providing remote e-voting and e-voting facilities through NSDL. Members holding shares as of the cut-off date, September 19, 2026, can cast their votes electronically. Remote e-voting will commence on September 27, 2026, at 9:00 AM IST and conclude on September 29, 2026, at 5:00 PM IST. The Notice of the 40th AGM and the Annual Report for the Financial Year 2025-26, containing the financial statements, are available on the company's website and the websites of the stock exchanges.
What to do with a filing like this
Trigyn Technologies Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Trigyn Technologies Limited. Read the original for the full detail.